Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06608680 · ClinicalTrials.gov registry record · NA
Timing and Facilitation Effects of Theta-Burst Stimulation in the Reading and Language Networks
A NA study of Language and Control Subjects, sponsored by Georgia State University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06608680: Recruiting NA study of Language and Control Subjects, sponsored by Georgia State University.
NCT06608680 is a NA study of Language and Control Subjects that is actively recruiting participants, run by Georgia State University. The registered enrollment target is 50 participants, below the 66-participant average among 6 other Language trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06608680, a NA study of Language and Control Subjects, is actively recruiting participants, sponsored by Georgia State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how transcranial magnetic stimulation affects how quickly, easily, and accurately a person read. Transcranial magnetic stimulation is a technique that uses magnetic fields to briefly affect how well certain brain regions function. The investigators would like to better understand how long the effects of transcranial magnetic stimulation occur in the reading system and at what point the effect is strongest in this system. The main questions it aims to answer are: 1. At what point after stimulation are the greatest effects on behavior seen 2. How excitatory and inhibitory stimulation affect behavior Researchers will compare stimulation types against a sham condition to see effects on reading and language behavior. Participants will be asked to * undergo reading, language, and cognitive testing * receive an MRI * receive TMS stimulation * perform language, reading, and motor tasks
Conditions Studied
Interventions
- BEHAVIORAL iTBS
- BEHAVIORAL cTBS
- BEHAVIORAL Sham Stimulation
Study Locations (1)
Georgia
- Georgia State University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT06608680 shows while recruiting
NCT06608680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 66-participant average among 6 other Language trials with a reported enrollment target (24% lower).
The record links to 3 conditions, with Language appearing as the primary indexed condition, and to 3 interventions - of which iTBS is the first listed.
NCT06608680 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06608680 about?
NCT06608680 is a clinical study titled "Timing and Facilitation Effects of Theta-Burst Stimulation in the Reading and Language Networks". The purpose of this study is to understand how transcranial magnetic stimulation affects how quickly, easily, and accurately a person read. Transcranial magnetic stimulation is a technique that uses magnetic fields to briefly affect how well certain brain regions function. The investigators would li...
What is the current status of trial NCT06608680?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-01. Estimated completion is 2028-12-31.
What conditions does trial NCT06608680 study?
This clinical trial studies the following conditions: Language, Control Subjects, Reading.
What interventions are being tested in trial NCT06608680?
The interventions under investigation include: iTBS (BEHAVIORAL), cTBS (BEHAVIORAL), Sham Stimulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06608680?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06608680 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Language
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuroplasticity Biomarkers in Aphasia
RECRUITING · NA
-
Language Processing and TMS
RECRUITING · NA
-
Computational Neuroscience of Language Processing in the Human Brain
RECRUITING · NA
-
Talk With Me Baby to Enhance the Early Home Language Environment
RECRUITING · NA
-
Post-Stroke Aphasia TMS
RECRUITING · NA
-
English as a Second Language Health Literacy Program
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI